Skip to main content
Erschienen in: Tumor Biology 3/2011

01.06.2011 | Research Article

Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China

verfasst von: Miao-zhen Qiu, Zhi-qiang Wang, Dong-sheng Zhang, Hui-yan Luo, Zhi-wei Zhou, Feng-hua Wang, Yu-hong Li, Wen-qi Jiang, Rui-hua Xu

Erschienen in: Tumor Biology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

The incidence of gastric cancer in young has increased steadily in the last decades. Little is known about the clinicopathologic features and prognostic factors of young adult gastric cancer patients. The clinicopathological characteristics of 294 young adult gastric cancer patients between 20 and 50 years old were reviewed retrospectively from hospital records in Sun Yat-Sen University Cancer Center between 1996 and 2006. They were compared with 706 elder patients 51 years of age or over. A steady increasing in the proportion of female in the gastric carcinoma patients as the age decreasing was found. The distinguishing histological features of young adult patients were higher percentage of poorly differentiated grade and distant metastasis. The distribution of tumor–nodes–metastasis (TNM) stage was similar between these two groups. The 5-year disease-specific survival rate in the young adult group was significantly higher than in the elderly group. More patients receiving adjuvant chemotherapy were found in the young adult group. Multivariable analysis demonstrated that TNM stage and presence of angiolymphatic invasion were the independent negative predictors of survival for young patients with gastric cancer. Gastric cancer in young patients differs from that in elderly patients including a lack of male predilection, more aggressive histologic features, and better survival rate.
Literatur
1.
Zurück zum Zitat Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;10:2137–50.CrossRef Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;10:2137–50.CrossRef
2.
Zurück zum Zitat Moore MA, Eser S, Igisinov N, Igisinov S, Mohagheghi MA, Mousavi-Jarrahi A, et al. Cancer epidemiology and control in North-Western and Central Asia—past, present and future. Asian Pac J Cancer Prev. 2010;11:17–32.PubMed Moore MA, Eser S, Igisinov N, Igisinov S, Mohagheghi MA, Mousavi-Jarrahi A, et al. Cancer epidemiology and control in North-Western and Central Asia—past, present and future. Asian Pac J Cancer Prev. 2010;11:17–32.PubMed
3.
Zurück zum Zitat Capocaccia R, De Angelis R, Frova L, Sant M, Buiatti E, Gatta G, et al. Estimation and projections of stomach cancer trends in Italy. Cancer Causes Control. 1995;6:339–46.PubMedCrossRef Capocaccia R, De Angelis R, Frova L, Sant M, Buiatti E, Gatta G, et al. Estimation and projections of stomach cancer trends in Italy. Cancer Causes Control. 1995;6:339–46.PubMedCrossRef
4.
Zurück zum Zitat Kitamura K, Yamaguchi T, Yamamoto K, Ichikawa D, Taniguchi H, Hagiwara A, et al. Clinicopathological analysis of gastric cancer in young adults. Hepatogastroenterology. 1996;43:1273–80.PubMed Kitamura K, Yamaguchi T, Yamamoto K, Ichikawa D, Taniguchi H, Hagiwara A, et al. Clinicopathological analysis of gastric cancer in young adults. Hepatogastroenterology. 1996;43:1273–80.PubMed
5.
Zurück zum Zitat Semba S, Yokozaki H, Yasui W, Tahara E. Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1(17q21) in young patients with gastric cancer. Int J Oncol. 1998;12:1245–51.PubMed Semba S, Yokozaki H, Yasui W, Tahara E. Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1(17q21) in young patients with gastric cancer. Int J Oncol. 1998;12:1245–51.PubMed
6.
Zurück zum Zitat Kitamura K, Taniguchi H, Yamaguchi T, Takahashi T. Early gastric cancer in young adults. Tohoku J Exp Med. 1996;179:93–100.PubMedCrossRef Kitamura K, Taniguchi H, Yamaguchi T, Takahashi T. Early gastric cancer in young adults. Tohoku J Exp Med. 1996;179:93–100.PubMedCrossRef
7.
Zurück zum Zitat Theuer CP, de Virgilio C, Keese G, French S, Arnell T, Tolmos J, et al. Gastric adenocarcinoma in patients 40 years of age and younger. Am J Surg. 1996;172:473–6.PubMedCrossRef Theuer CP, de Virgilio C, Keese G, French S, Arnell T, Tolmos J, et al. Gastric adenocarcinoma in patients 40 years of age and younger. Am J Surg. 1996;172:473–6.PubMedCrossRef
8.
Zurück zum Zitat Matley PJ, Dent DM, Madden MV, Price SK. Gastric carcinoma in young adults. Ann Surg. 1988;208:593–6.PubMedCrossRef Matley PJ, Dent DM, Madden MV, Price SK. Gastric carcinoma in young adults. Ann Surg. 1988;208:593–6.PubMedCrossRef
9.
Zurück zum Zitat McNeer G. Cancer of the stomach in the young. Am J Roentgenol. 1941;41:537–50. McNeer G. Cancer of the stomach in the young. Am J Roentgenol. 1941;41:537–50.
10.
Zurück zum Zitat Kath R, Fiehler J, Schneider CP, Höffken K. Gastric cancer in very young adults: apropos four patients and a review of the literature. J Cancer Res Clin Oncol. 2000;126:233–7.PubMedCrossRef Kath R, Fiehler J, Schneider CP, Höffken K. Gastric cancer in very young adults: apropos four patients and a review of the literature. J Cancer Res Clin Oncol. 2000;126:233–7.PubMedCrossRef
11.
Zurück zum Zitat Hall TJ, Moulder J, Hsu HS, Achord J, Scott-Conner CE. Gastric carcinoma among younger individuals in Mississippi. South Med J. 1993;86:302–4.PubMedCrossRef Hall TJ, Moulder J, Hsu HS, Achord J, Scott-Conner CE. Gastric carcinoma among younger individuals in Mississippi. South Med J. 1993;86:302–4.PubMedCrossRef
12.
Zurück zum Zitat Bloss RS, Miller TA, Copeland 3rd EM. Carcinoma of the stomach in the young adult. Surg Gynecol Obstet. 1980;150:883–6.PubMed Bloss RS, Miller TA, Copeland 3rd EM. Carcinoma of the stomach in the young adult. Surg Gynecol Obstet. 1980;150:883–6.PubMed
13.
14.
Zurück zum Zitat Katai H, Sasako M, Sano T, Maruyama K. Gastric carcinoma in young adults. Jpn J Clin Oncol. 1996;26:139–43.PubMed Katai H, Sasako M, Sano T, Maruyama K. Gastric carcinoma in young adults. Jpn J Clin Oncol. 1996;26:139–43.PubMed
15.
Zurück zum Zitat Kojima O, Takahashi T, Kawakami S, Uehara Y, Matsui M. Localization of estrogen receptors in gastric cancer using immunohistochemical staining of monoclonal antibody. Cancer. 1991;67:2401–6.PubMedCrossRef Kojima O, Takahashi T, Kawakami S, Uehara Y, Matsui M. Localization of estrogen receptors in gastric cancer using immunohistochemical staining of monoclonal antibody. Cancer. 1991;67:2401–6.PubMedCrossRef
16.
Zurück zum Zitat Nishi K, Tokunaga A, Shimizu Y, Yoshiyuki T, Wada M, Matsukura N, et al. Immunohistochemical study of intracellular estradiol in human gastric cancer. Cancer. 1987;59:1328–32.PubMedCrossRef Nishi K, Tokunaga A, Shimizu Y, Yoshiyuki T, Wada M, Matsukura N, et al. Immunohistochemical study of intracellular estradiol in human gastric cancer. Cancer. 1987;59:1328–32.PubMedCrossRef
17.
Zurück zum Zitat Mori M, Sugimachi K, Ohiwa T, Okamura T, Tamura S, Inokuchi K. Early gastric carcinoma in Japanese patients under 30 years of age. Br J Surg. 1985;72:289–91.PubMedCrossRef Mori M, Sugimachi K, Ohiwa T, Okamura T, Tamura S, Inokuchi K. Early gastric carcinoma in Japanese patients under 30 years of age. Br J Surg. 1985;72:289–91.PubMedCrossRef
18.
Zurück zum Zitat Tso PL, Bringaze 3rd WL, Dauterive AH, Correa P, Cohn Jr I. Gastric carcinoma in the young. Cancer. 1987;59:1362–5.PubMedCrossRef Tso PL, Bringaze 3rd WL, Dauterive AH, Correa P, Cohn Jr I. Gastric carcinoma in the young. Cancer. 1987;59:1362–5.PubMedCrossRef
19.
Zurück zum Zitat Miller AB. Risk factors from geographic epidemiology for gastrointestinal cancer. Cancer. 1982;50:2533–40.PubMed Miller AB. Risk factors from geographic epidemiology for gastrointestinal cancer. Cancer. 1982;50:2533–40.PubMed
20.
Zurück zum Zitat Zeng Z, Cohen AM, Urmacher C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum. 1993;36:1063–8.PubMedCrossRef Zeng Z, Cohen AM, Urmacher C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum. 1993;36:1063–8.PubMedCrossRef
21.
Zurück zum Zitat Qiu MZ, Lin JZ, Wang ZQ, Wang FH, Pan ZZ, Luo HY, et al. Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19–9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma. Int J Biol Markers. 2009;24:258–64.PubMed Qiu MZ, Lin JZ, Wang ZQ, Wang FH, Pan ZZ, Luo HY, et al. Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19–9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma. Int J Biol Markers. 2009;24:258–64.PubMed
22.
Zurück zum Zitat Panzini I, Gianni L, Fattori PP, Tassinari D, Imola M, Fabbri P, et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori. 2002;88:21–7.PubMed Panzini I, Gianni L, Fattori PP, Tassinari D, Imola M, Fabbri P, et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori. 2002;88:21–7.PubMed
23.
Zurück zum Zitat Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg. 2009;96:26–33.PubMedCrossRef Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer. Br J Surg. 2009;96:26–33.PubMedCrossRef
24.
Zurück zum Zitat Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol. 2002;9:562–7.PubMedCrossRef Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol. 2002;9:562–7.PubMedCrossRef
25.
Zurück zum Zitat Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828–35. discussion 835–837.PubMed Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828–35. discussion 835–837.PubMed
26.
Zurück zum Zitat Setälä LP, Kosma VM, Marin S, Lipponen PK, Eskelinen MJ, Syrjänen KJ, et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer. 1996;74:766–72.PubMedCrossRef Setälä LP, Kosma VM, Marin S, Lipponen PK, Eskelinen MJ, Syrjänen KJ, et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer. 1996;74:766–72.PubMedCrossRef
Metadaten
Titel
Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China
verfasst von
Miao-zhen Qiu
Zhi-qiang Wang
Dong-sheng Zhang
Hui-yan Luo
Zhi-wei Zhou
Feng-hua Wang
Yu-hong Li
Wen-qi Jiang
Rui-hua Xu
Publikationsdatum
01.06.2011
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 3/2011
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-010-0145-2

Weitere Artikel der Ausgabe 3/2011

Tumor Biology 3/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.